Sex Differences in the Association of Urinary Concentrations of Phthalates Metabolites with Self-Reported Diabetes and Cardiovascular Diseases in Shanghai Adults

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2017 Jun 8

PMID 28587233

Citations 12

Authors

Ruihua Dong

Shanzhen Zhao

Han Zhang

Jingsi Chen

Meiru Zhang

Min Wang

Min Wu

Shuguang Li

Bo Chen

Affiliations

Soon will be listed here.

Abstract

Phthalate exposure was reported to be associated with diabetes mellitus (DM) and cardiovascular disease (CVD). Yet, reported associations and the potential sex differences are inconsistent. We conducted a cross-sectional study involving 2330 participants in the Fall of 2012. Urinary metabolites of 10 phthalates were measured. The status of having DM and CVD-related outcomes were self-reported. In the overall study population, the logistic regression analyses showed that the urinary levels of mono-2-ethyl-5-oxohexyphthalate (MEOHP), mono-2-ethyl-5-hydroxyhexylphthalate(MEHHP) and mono-2-ethyl-5-carboxypentylphthalate (MECPP) were positively associated with DM. Higher urinary levels of monomethyl phthalate (MMP) and mono-2-carboxymethyl-hexyl phthalate (MCMHP) were associated with increased odds of hyperlipidemia, while mono-2-ethylhexylphthalate (MEHP) was significantly inverse-associated with hyperlipidemia. We did not observe significant associations for other CVD-related outcomes with phthalate metabolites. When stratifying by sex, MEHHP, MEOHP, MECPP, MCMHP and the micromolar sums of the oxidative metabolites of DEHP (ΣDEHP) were all significantly related to DM in males, but not in females. No significant sex differences were found in CVD-related outcomes, except the sporadic associations between phthalates and hyperlipidemia. These findings highlight the importance of investigating the sex-specific relationship between phthalates exposure and DM.

Citing Articles

Association of Multiple Urinary Phthalates Metabolites with Diabetes Risk in Elderly Population.

Wang Y, Chen J, Shi J, Zhao Z, Chen J, Deng Y Environ Health (Wash). 2024; 2(3):140-149.

PMID: 39473819 PMC: 11504536. DOI: 10.1021/envhealth.3c00120.

The Hidden Threat: Endocrine Disruptors and Their Impact on Insulin Resistance.

Dagar M, Kumari P, Mirza A, Singh S, Ain N, Munir Z Cureus. 2023; 15(10):e47282.

PMID: 38021644 PMC: 10656111. DOI: 10.7759/cureus.47282.

The Relationship between Phthalates and Diabetes: A Review.

Mariana M, Cairrao E Metabolites. 2023; 13(6).

PMID: 37367903 PMC: 10301313. DOI: 10.3390/metabo13060746.

The effect of apigenin, an aryl hydrocarbon receptor antagonist, in Phthalate-Exacerbated eosinophilic asthma model.

Kim S, Luu Quoc Q, Park H, Shin Y J Cell Mol Med. 2023; 27(13):1900-1910.

PMID: 37315181 PMC: 10315829. DOI: 10.1111/jcmm.17804.

Endocrine disruptors in plastics alter β-cell physiology and increase the risk of diabetes mellitus.

Martinez-Pinna J, Sempere-Navarro R, Medina-Gali R, Fuentes E, Quesada I, Sargis R Am J Physiol Endocrinol Metab. 2023; 324(6):E488-E505.

PMID: 37134142 PMC: 10228669. DOI: 10.1152/ajpendo.00068.2023.

References

Warembourg C, Debost-Legrand A, Bonvallot N, Massart C, Garlantezec R, Monfort C . Exposure of pregnant women to persistent organic pollutants and cord sex hormone levels. Hum Reprod. 2015; 31(1):190-8. DOI: 10.1093/humrep/dev260. View

Schettler T . Human exposure to phthalates via consumer products. Int J Androl. 2006; 29(1):134-9. DOI: 10.1111/j.1365-2605.2005.00567.x. View

Fromme H, Bolte G, Koch H, Angerer J, Boehmer S, Drexler H . Occurrence and daily variation of phthalate metabolites in the urine of an adult population. Int J Hyg Environ Health. 2006; 210(1):21-33. DOI: 10.1016/j.ijheh.2006.09.005. View

Wisse B . The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004; 15(11):2792-800. DOI: 10.1097/01.ASN.0000141966.69934.21. View

Koch H, Bolt H, Preuss R, Angerer J . New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch Toxicol. 2005; 79(7):367-76. DOI: 10.1007/s00204-004-0642-4. View

Dong R, Zhou T, Zhao S, Zhang H, Zhang M, Chen J . Food consumption survey of Shanghai adults in 2012 and its associations with phthalate metabolites in urine. Environ Int. 2017; 101:80-88. DOI: 10.1016/j.envint.2017.01.008. View

Han X, Cui Z, Zhou N, Ma M, Li L, Li Y . Urinary phthalate metabolites and male reproductive function parameters in Chongqing general population, China. Int J Hyg Environ Health. 2013; 217(2-3):271-8. DOI: 10.1016/j.ijheh.2013.06.006. View

James-Todd T, Stahlhut R, Meeker J, Powell S, Hauser R, Huang T . Urinary phthalate metabolite concentrations and diabetes among women in the National Health and Nutrition Examination Survey (NHANES) 2001-2008. Environ Health Perspect. 2012; 120(9):1307-13. PMC: 3440117. DOI: 10.1289/ehp.1104717. View

Meeker J, Calafat A, Hauser R . Urinary metabolites of di(2-ethylhexyl) phthalate are associated with decreased steroid hormone levels in adult men. J Androl. 2008; 30(3):287-97. PMC: 2772199. DOI: 10.2164/jandrol.108.006403. View

10.

Martino-Andrade A, Chahoud I . Reproductive toxicity of phthalate esters. Mol Nutr Food Res. 2009; 54(1):148-57. DOI: 10.1002/mnfr.200800312. View

11.

Ding E, Song Y, Malik V, Liu S . Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006; 295(11):1288-99. DOI: 10.1001/jama.295.11.1288. View

12.

Guo Y, Alomirah H, Cho H, Minh T, Ali Mohd M, Nakata H . Occurrence of phthalate metabolites in human urine from several Asian countries. Environ Sci Technol. 2011; 45(7):3138-44. DOI: 10.1021/es103879m. View

13.

Svensson K, Hernandez-Ramirez R, Burguete-Garcia A, Cebrian M, Calafat A, Needham L . Phthalate exposure associated with self-reported diabetes among Mexican women. Environ Res. 2011; 111(6):792-6. PMC: 5240471. DOI: 10.1016/j.envres.2011.05.015. View

14.

Barr D, Wilder L, Caudill S, Gonzalez A, Needham L, Pirkle J . Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 2005; 113(2):192-200. PMC: 1277864. DOI: 10.1289/ehp.7337. View

15.

Lind P, Roos V, Ronn M, Johansson L, Ahlstrom H, Kullberg J . Serum concentrations of phthalate metabolites are related to abdominal fat distribution two years later in elderly women. Environ Health. 2012; 11:21. PMC: 3379932. DOI: 10.1186/1476-069X-11-21. View

16.

Stahlhut R, van Wijngaarden E, Dye T, Cook S, Swan S . Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect. 2007; 115(6):876-82. PMC: 1892109. DOI: 10.1289/ehp.9882. View

17.

Specht I, Toft G, Hougaard K, Lindh C, Lenters V, Jonsson B . Associations between serum phthalates and biomarkers of reproductive function in 589 adult men. Environ Int. 2014; 66:146-56. DOI: 10.1016/j.envint.2014.02.002. View

18.

Sheikh I, Yasir M, Abu-Elmagd M, Dar T, Abuzenadah A, Damanhouri G . Human sex hormone-binding globulin as a potential target of alternate plasticizers: an in silico study. BMC Struct Biol. 2016; 16(Suppl 1):15. PMC: 5056528. DOI: 10.1186/s12900-016-0067-3. View

19.

Ferguson K, Cantonwine D, Rivera-GonzAlez L, Loch-Caruso R, Mukherjee B, Del Toro L . Urinary phthalate metabolite associations with biomarkers of inflammation and oxidative stress across pregnancy in Puerto Rico. Environ Sci Technol. 2014; 48(12):7018-25. PMC: 4066910. DOI: 10.1021/es502076j. View

20.

Liu S, Sun Q . Sex differences, endogenous sex-hormone hormones, sex-hormone binding globulin, and exogenous disruptors in diabetes and related metabolic outcomes. J Diabetes. 2016; 10(6):428-441. DOI: 10.1111/1753-0407.12517. View